Quantcast
Investor's Business Daily investors.com 09 Nov, 2023 16:30 am

Biotech Crashes As New ALS Drug Faces A Barrage Of Troubles

Biotech Crashes As New ALS Drug Faces A Barrage Of Troubles
Amylyx missed Wall Street's expectations on Thursday amid struggles for its amyotrophic lateral sclerosis drug, and AMLX stock crashed.
Read full story at investors.com